Evidence map›Paper›PMID 31337999›Full record

ReviewEXCLI journal2019

Rhomboid antigens are promising targets in the vaccine development against

Masoud Foroutan, Leila Zaki, Sanaz Tavakoli, Shahrzad Soltani, Ali Taghipour, Fatemeh Ghaffarifar

Open access · greenAbstract readReview
In one paragraph

Review in EXCLI journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. PLGA nanoparticles as an efficient carrier inFrontiers in immunology · 2025
    Article
  3. Bioinformatics and biology insights · 2025
    Article
  4. Global prevalence ofParasite epidemiology and control · 2024
    Review
  5. Heliyon · 2024
    Review
  6. Mining the Proteome ofAnimals : an open access journal from MDPI · 2022
    Review
  7. Nano vaccines forFrontiers in immunology · 2022
    Article
  8. Protective efficacy induced byFrontiers in veterinary science · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Discovery of New Microneme Proteins inFrontiers in veterinary science · 2021
    Article
  13. Article
  14. Article
  15. In-depth computational analysis of calcium-dependent protein kinase 3 ofClinical and experimental vaccine research · 2020
    Article
  16. EXCLI journal · 2020
    Article
  17. Article
  18. Effect of Imiquimod on Tachyzoites ofFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Masoud ForoutanAbadan School of Medical Sciences, Abadan, Iran.
Leila ZakiDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Sanaz TavakoliDepartment of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Shahrzad SoltaniAbadan School of Medical Sciences, Abadan, Iran.
Ali TaghipourDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Fatemeh GhaffarifarDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Tarbiat Modares University · IRIsfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvantimmunizationrhomboidToxoplasma gondiivaccines

Identifiers

PMID31337999
PMCPMC6635731
OpenAlexW2948357439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.